Cargando…
The osmo-metabolic approach: a novel and tantalizing glucose-sparing strategy in peritoneal dialysis
Peritoneal dialysis (PD) is a viable but under-prescribed treatment for uremic patients. Concerns about its use include the bio-incompatibility of PD fluids, due to their potential for altering the functional and anatomical integrity of the peritoneal membrane. Many of these effects are thought to b...
Autores principales: | Bonomini, Mario, Zammit, Victor, Divino-Filho, José C., Davies, Simon J., Di Liberato, Lorenzo, Arduini, Arduino, Lambie, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036224/ https://www.ncbi.nlm.nih.gov/pubmed/32767274 http://dx.doi.org/10.1007/s40620-020-00804-2 |
Ejemplares similares
-
Effect of peritoneal dialysis fluid containing osmo-metabolic agents on human endothelial cells
por: Bonomini, Mario, et al.
Publicado: (2016) -
Current Opinion on Usage of L-Carnitine in End-Stage Renal Disease Patients on Peritoneal Dialysis
por: Bonomini, Mario, et al.
Publicado: (2019) -
A New Peritoneal Dialysis Solution Containing L-Carnitine and Xylitol for Patients on Continuous Ambulatory Peritoneal Dialysis: First Clinical Experience
por: Rago, Carmela, et al.
Publicado: (2021) -
How to Improve the Biocompatibility of Peritoneal Dialysis Solutions (without Jeopardizing the Patient’s Health)
por: Bonomini, Mario, et al.
Publicado: (2021) -
Proteomic Research in Peritoneal Dialysis
por: Bonomini, Mario, et al.
Publicado: (2020)